Skip to main content

Pfizer and Merck’s third-quarter numbers bolster hopes for drug company earnings

Pfizer Inc. and Merck & Co. cheered investors with better-than-expected earnings on Tuesday, bolstering expectations for the drug sector and sending both Dow Jones Industrial Average components higher in early trade.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.